<DOC>
	<DOCNO>NCT00430547</DOCNO>
	<brief_summary>The purpose study determine whether radioactive iodine , compare anti-thyroid medication , risk factor development progression thyroid-associated ophthalmopathy patient hyperthyroidism due Graves ' disease . The aim study determine incidence various ophthalmopathy subtypes utility orbital antibody diagnosis , classification monitoring patient thyroid-associated ophthalmopathy .</brief_summary>
	<brief_title>Thyroid-Associated Ophthalmopathy Subtypes Orbital Antibodies</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Carbimazole</mesh_term>
	<criteria>Graves ' disease diagnose last 3 month , regardless presence ophthalmopathy Preexisting eye disease : e.g . orbital surgery , orbital irradiation significant loss vision Age &lt; 18 year Inability consent participation study Pregnancy History radioactive iodine therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2003</verification_date>
</DOC>